Investing Ideas
/
Egyptian Pharmaceuticals & Biotech Sustainable Track Record

Egyptian Pharmaceuticals & Biotech Sustainable Track Record

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.

3 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MPCI Memphis Pharmaceuticals & Chemical Industries	ج.م51.98	-2.3%	-13.9%	ج.م292.4m	n/a	PE1x	n/a	7.7%
CPCI Kahira Pharmaceuticals & Chemical Industries	ج.م99.04	-15.4%	75.1%	ج.م1.5b	n/a	PE6x	n/a	13.0%
PHAR Egyptian International Pharmaceutical Industries	ج.م44.11	-2.9%	21.4%	ج.م6.6b	ج.م77.62	PE5.6x	S17.2%	2.3%

Page 1 of 1